Redwood Investments’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-180,715
Closed -$10.7M 127
2022
Q2
$10.7M Buy
180,715
+24,090
+15% +$1.98M 1.19% 35
2022
Q1
$18.2M Sell
156,625
-68
-0% -$7.94K 1.72% 22
2021
Q4
$23.6M Sell
156,693
-2,306
-1% -$311K 1.86% 14
2021
Q3
$19M Buy
158,999
+31,688
+25% +$3.49M 1.59% 20
2021
Q2
$12.4M Buy
127,311
+25,397
+25% +$2.26M 1% 45
2021
Q1
$8.99M Sell
101,914
-16,483
-14% -$1.53M 0.79% 51
2020
Q4
$11.3M Sell
118,397
-15,530
-12% -$1.6M 0.96% 48
2020
Q3
$15.2M Sell
133,927
-53,469
-29% -$5.62M 1.28% 33
2020
Q2
$18.5M Buy
187,396
+3,394
+2% +$271K 1.64% 20
2020
Q1
$11.8M Sell
184,002
-32,601
-15% -$2.28M 1.4% 30
2019
Q4
$12.9M Sell
216,603
-99,039
-31% -$6.11M 1.21% 43
2019
Q3
$18.6M Buy
+315,642
New +$20.1M 1.43% 24

Other funds holding TNDM

Redwood Investments's TNDM Position: Q3 2022 in Review

Redwood Investments sold out of Tandem Diabetes Care (TNDM) in Q3 2022, closing a stake of 180,715 shares — an estimated $10.7M sold.

Redwood Investments first reported a position in TNDM in Q3 2019 and held it in 12 quarters. The position peaked at $23.6M in Q4 2021. 299 funds tracked by Wall St. Rank hold TNDM as of Q3 2022.

  • Redwood Investments reported no remaining Tandem Diabetes Care position as of Q3 2022 after selling out during the quarter.
  • Redwood Investments sold 180,715 Tandem Diabetes Care shares in Q3 2022, an estimated $10.7M.
  • Redwood Investments first reported a position in Tandem Diabetes Care in Q3 2019 and held it in 12 quarters.
  • Redwood Investments's Tandem Diabetes Care position peaked at $23.6M in Q4 2021.
  • 299 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2022.

Based on Redwood Investments's 13F filing for Q3 2022, filed 28 Oct 2022.